Member Info for Jarv55

just a reminder https://twitter.com/francisbrett/status/1226970357887832069?s=12

Think people are crazy selling this but there you go.

Trade it, slice it do whatever but don't deramp when you have sold its not cricket. I am staying in for the news.

warrants will give us more cash

And it could be wrrants being converted.

chart update https://twitter.com/Jarvy55/status/1227143800973398016

Nice shake

https://www.dailyecho.co.uk/news/18224218.st-marys-independent-school-southampton-closed-evacuated-coronavirus-fears/

Mornington Oz well done on your profits now move along son.

Wonder where Maria is hope everyone ignored her him

near the end https://news.sky.com/story/watch-sky-news-live-10315632 they are working on a faster test

No need to ramp this they will need as many tests as they can get from lots of companies.

Mixes with the big boys does Graham https://www.mining.com/graham-briggs-to-retire-as-the-ceo-of-harmony-gold/4/

Ignore the gaps on the 15mins chart they are not relevant and actually just ignore the noise
HIGHLIGHTS

· The JV Partners have now formed a JV management committee to provide managerial oversight for the Project and both Blyvoor and Katoro have appointed two representatives;

· The JV management committee have appointed Graham Briggs, former CEO of Harmony Gold Mining Company Limited, as Manager of the JV;

· Mr Briggs will be responsible for control, management and supervision of all technical, operational and other activities relating to the Project; and

· The JV management committee has already met and is seeking to advance the Project.



Biography JV Manager - Graham Briggs



Graham Briggs, has a long and distinguished career in the South African mining industry and brings extensive operational experience to the Project. Having commenced his career in the early 1970s as a geologist, he initially worked for several gold mining companies in the Gencor Group.



He subsequently joined Harmony Gold Mining Company Limited in 1995 as a New Business Manager, before being appointed as its Chief Executive Officer in 2008, serving in the role until his retirement in 2015.



As a result, Graham has extensive operational and managerial experience from his involvement with several South African gold mines and extensive international experience, working as CEO of Harmony operations in Canada, Australia and Papua New Guinea.



Graham was also vice president of the Chamber of Mines of South Africa for two years until 2016.





Louis Coetzee, Executive Chairman of Katoro, said: "The formation of the JV management committee is an important step in the development of the Project and we are delighted to have achieved this so quickly.



"We are also delighted to have Graham Briggs on board as the JV Manager. He brings a wealth of experience and knowledge to the Project, having near 50 years' of experience in the mining sector, demonstrating the significant nature of the Project and the important need for an experienced hand at the controls.



"We are now moving forward multiple work streams to advance the Project and look forward to keeping shareholders updated on our progress."

JIM CAN YOU PLEASE READ THIS https://aim-watch.com/articles/price-monitoring-extensions-explained/

https://www.itv.com/news/2020-02-10/coronavirus-death-toll-climbs-to-908/

This will have a Eua rise

https://www.bioworld.com/articles/432813-hhs-declares-public-health-emergency-in-part-because-cdc-test-for-coronavirus-unreliable

Ncyt tests only for this latest out break the cds test has been shown to be unreliable

The fear of the coronavirus has been spread to the financial markets, but it is also behind the meteoric rally that is recorded by the French biopharmaceutical Novacyt. Thanks to the launch of a test to detect the coronavirus, in the last eight sessions it accumulates a rally higher than 350%. The size of the economic alerts on the Chinese coronavirus has forced investors to try to protect themselves from its effects on financial markets. But in addition to adopting a more defensive profile, this situation has also surfaced some investment opportunities. Pharmaceuticals and facial mask manufacturers are in the spotlight of investors as potential beneficiaries. When identifying potential beneficiaries in the stock market, the French biopharmaceutical company Novacyt runs out of rivals in Europe. The company has become the star value of the last days in the European stock exchanges. The company specialized in diagnosis of diseases entered a new dimension on the stock market on January 31, when it announced the launch of a specific test to detect the coronavirus. The company highlighted at the time that it was the first test available in Europe to detect the coronavirus, and that before its launch it had already received numerous orders from more than a dozen countries. The forecasts of a massive demand for this test, which allows to know the result of the possible contagion in less than two hours, have put into action the actions of Novacyt. On January 30, a day before the official announcement of the new test, began a meteoric rally that persists today. The biopharmaceutical shot up 33% on January 30, a percentage that shot up 88% a day later, coinciding with the launch of the new test to detect the coronavirus. Since January 30, in six of the eight days their titles have closed with increases higher than double digits. The revaluation in today's day once again exceeds the 40% threshold. The magnitude of this rally triggers its shares at intraday highs above the level of 0.80 euros. Only in the last eight days, since January 30, Novacyt accumulates a revaluation of over 350%. The reduced liquidity of the biopharmaceutical on the stock exchange, due to its small size, helps to multiply the effects of the wave of purchase orders that it is receiving in recent days..